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Aim
Prolactinoma is the most prevalent pituitary tumor that
accounts for 40% of all pituitary tumors. It is more preva-
lent in adults with an estimated prevalence of 100/million,
however, it is very rare in childhood and adolescents and
clinical spectrums and long-term prognosis remain
unclear. The most common clinical manifestations have
been known to be growth and pubertal disorders. This
study investigated clinical and endocrine characteristics,
and treatment outcome of prolactinoma in children and
adolescents.
Methods
Six patients (3 males and 3 females) with prolactinoma
diagnosed before 18 years of age were included. The diag-
nosis and relapse of prolactinoma were confirmed by brain
magnetic resonance imaging (MRI) and serum prolactin
level. The clinical course, endocrinological characteristics,
and radiologic findings were reviewed retrospectively.
Results
The mean age at diagnosis was 12.2 years (range, 7-15
years). Two boys presented with visual disturbance while
the other boy complained galactorrhea and stunted growth
velocity. All three girls manifested galactorrhea and two of
them also displayed secondary amenorrhea. The mean
level of prolactin before treatment was 397.5±315.7 ng/mL
(106-946). MRI of the pituitary showed macroadenoma in
5 patients, while 1 female had microadenoma. One male
and three females were successfully treated with bromo-
criptine. The mean duration of medical treatment with
bromocriptine was 4.8 years (0.1-11). Two girls who had
macroadenoma failed to normalize serum prolactin level
and therefore underwent transsphenoidal surgery.
Galactorhhea disappeared and all girls returned to regular
menstrual period. The boy who showed growth retardation
came back to normal growth velocity after prolacin level
reached normal range. Two boys with visual disturbance
underwent an operation at the time of diagnosis being sus-
picious of craniopharyngioma. After tumor resection they
have been under multiple hormone replacement therapy.
These two boys had recurrent prolactinoma despite medical
treatment and underwent additional surgery and radiation
therapy. One boy has not been followed-up and the other
has been treated with carbegoline but the fourth operation
is under contemplation.
Conclusion
Children and adolescents with prolactinomas exhibits wide
spectrum of clinical presentations. Multimodal treatment
such as surgery or radiotherapy may be necessary in some
cases who are resistant to dopamine agonists. The patients
with high prolactin level and macroadenoma were
resistant to medical treatment and had high relapse rate.
Long-term follow-up for large cohort of patients with
prolactinemia should be needed to delineate clinical
course and prognosis.
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